Digital pathology matured quickly during the pandemic, when remote work needs and temporary FDA enforcement discretion lowered the perceived barriers to whole-slide imaging. Capital followed. Roche’s May agreement to acquire PathAI for up to $1.05 billion, pending closing, is only the most recent sign of how much money is chasing the field. The most valuable… The post Leica, Indica Labs and Lunit…
Digital pathology has revolutionized the field of medicine by enabling the analysis of whole slide images (WSIs) on computers. However, challenges remain, such as the need for large, high-quality datasets for training machine learning models. Researchers have introduced Prov-GigaPath, a new pathology foundation model, in a recent breakthrough. Prov-GigaPath was pre-trained on a massive dataset of…
